List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Natural Killer (NK) Cell Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Natural Killer (NK) Cell Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Natural Killer (NK) Cell Therapeutics Market Size for the Year 2017-2028
1.3 Natural Killer (NK) Cell Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Natural Killer (NK) Cell Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Natural Killer (NK) Cell Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Natural Killer (NK) Cell Therapeutics Market Dynamics
1.4.1 Natural Killer (NK) Cell Therapeutics Industry Trends
1.4.2 Natural Killer (NK) Cell Therapeutics Market Drivers
1.4.3 Natural Killer (NK) Cell Therapeutics Market Challenges
1.4.4 Natural Killer (NK) Cell Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Natural Killer (NK) Cell Therapeutics by Type
2.1 Natural Killer (NK) Cell Therapeutics Market Segment by Type
2.1.1 Mogamulizumab
2.1.2 Lorvotuzumab Mertansine
2.1.3 Others
2.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2028)
2.4 United States Natural Killer (NK) Cell Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2028)
3 Natural Killer (NK) Cell Therapeutics by Application
3.1 Natural Killer (NK) Cell Therapeutics Market Segment by Application
3.1.1 Cancer
3.1.2 Cardiovascular Diseases
3.1.3 Others
3.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2028)
3.4 United States Natural Killer (NK) Cell Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2028)
4 Global Natural Killer (NK) Cell Therapeutics Competitor Landscape by Company
4.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Company
4.1.1 Top Global Natural Killer (NK) Cell Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Player (2017-2022)
4.2 Global Natural Killer (NK) Cell Therapeutics Concentration Ratio (CR)
4.2.1 Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Natural Killer (NK) Cell Therapeutics in 2021
4.2.3 Global Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Natural Killer (NK) Cell Therapeutics Headquarters, Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Natural Killer (NK) Cell Therapeutics Headquarters and Area Served
4.3.2 Global Natural Killer (NK) Cell Therapeutics Companies Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Natural Killer (NK) Cell Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Natural Killer (NK) Cell Therapeutics Market Size by Company
4.5.1 Top Natural Killer (NK) Cell Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Natural Killer (NK) Cell Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Natural Killer (NK) Cell Therapeutics Market Size by Region
5.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Natural Killer (NK) Cell Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Natural Killer (NK) Cell Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Natural Killer (NK) Cell Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Natural Killer (NK) Cell Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Chipscreen Biosciences
7.1.1 Chipscreen Biosciences Company Details
7.1.2 Chipscreen Biosciences Business Overview
7.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Introduction
7.1.4 Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.1.5 Chipscreen Biosciences Recent Development
7.2 Affimed NV
7.2.1 Affimed NV Company Details
7.2.2 Affimed NV Business Overview
7.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Introduction
7.2.4 Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.2.5 Affimed NV Recent Development
7.3 Altor BioScience
7.3.1 Altor BioScience Company Details
7.3.2 Altor BioScience Business Overview
7.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Introduction
7.3.4 Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.3.5 Altor BioScience Recent Development
7.4 Innate Pharma
7.4.1 Innate Pharma Company Details
7.4.2 Innate Pharma Business Overview
7.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Introduction
7.4.4 Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.4.5 Innate Pharma Recent Development
7.5 Takeda
7.5.1 Takeda Company Details
7.5.2 Takeda Business Overview
7.5.3 Takeda Natural Killer (NK) Cell Therapeutics Introduction
7.5.4 Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.5.5 Takeda Recent Development
7.6 Sorrento Therapeutics
7.6.1 Sorrento Therapeutics Company Details
7.6.2 Sorrento Therapeutics Business Overview
7.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Introduction
7.6.4 Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.6.5 Sorrento Therapeutics Recent Development
7.7 NantKwest
7.7.1 NantKwest Company Details
7.7.2 NantKwest Business Overview
7.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Introduction
7.7.4 NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.7.5 NantKwest Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Introduction
7.8.4 Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.8.5 Bristol-Myers Squibb Recent Development
7.9 NKT
7.9.1 NKT Company Details
7.9.2 NKT Business Overview
7.9.3 NKT Natural Killer (NK) Cell Therapeutics Introduction
7.9.4 NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.9.5 NKT Recent Development
7.10 Henry Ford Health Services
7.10.1 Henry Ford Health Services Company Details
7.10.2 Henry Ford Health Services Business Overview
7.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Introduction
7.10.4 Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
7.10.5 Henry Ford Health Services Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
